1. Home
  2. DAKT vs EVMN Comparison

DAKT vs EVMN Comparison

Compare DAKT & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Daktronics Inc.

DAKT

Daktronics Inc.

HOLD

Current Price

$20.09

Market Cap

944.7M

Sector

Industrials

ML Signal

HOLD

Logo Evommune Inc.

EVMN

Evommune Inc.

HOLD

Current Price

$15.53

Market Cap

869.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAKT
EVMN
Founded
1968
2020
Country
United States
United States
Employees
N/A
48
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
944.7M
869.1M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
DAKT
EVMN
Price
$20.09
$15.53
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
$43.88
AVG Volume (30 Days)
477.1K
547.8K
Earning Date
03-04-2026
06-11-2026
Dividend Yield
N/A
N/A
EPS Growth
538.10
N/A
EPS
0.92
N/A
Revenue
$608,932,000.00
N/A
Revenue This Year
$12.06
N/A
Revenue Next Year
$9.16
N/A
P/E Ratio
$21.23
N/A
Revenue Growth
6.89
N/A
52 Week Low
$14.87
$13.89
52 Week High
$28.27
$33.20

Technical Indicators

Market Signals
Indicator
DAKT
EVMN
Relative Strength Index (RSI) 51.53 32.04
Support Level $19.08 N/A
Resistance Level $20.55 $20.37
Average True Range (ATR) 1.07 1.72
MACD -0.05 -0.01
Stochastic Oscillator 41.18 0.09

Price Performance

Historical Comparison
DAKT
EVMN

About DAKT Daktronics Inc.

Daktronics Inc designs and manufactures electronic scoreboards, programmable display systems, and large-screen video displays for sporting, commercial, and transportation applications. It is engaged in a full range of activities: marketing and sales, engineering and product design and development, manufacturing, technical contracting, professional services, and customer service and support. The company offers a complete line of products, from small scoreboards and electronic displays to large multimillion-dollar video display systems as well as related control, timing, and sound systems. The company has five reportable segments: Commercial, Live Events, High School Park and Recreation, Transportation, and International. The company makes the majority of its revenue from Live events.

About EVMN Evommune Inc.

Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.

Share on Social Networks: